rs34439278
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3_Moderate
The NM_000518.5(HBB):c.170G>A(p.Gly57Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G57R) has been classified as Likely benign.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.170G>A | p.Gly57Asp | missense_variant | 2/3 | ENST00000335295.4 | NP_000509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.170G>A | p.Gly57Asp | missense_variant | 2/3 | 1 | NM_000518.5 | ENSP00000333994 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152092Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251448Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135892
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461874Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 727244
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Dec 12, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 16, 2024 | Variant summary: HBB c.170G>A (p.Gly57Asp) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 251448 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.170G>A was identified in the literature in heterozygous carriers who were clinically normal (e.g. Blackwell_1966, Pootrakul_1967). It has also been reported in the compound heterozygous state with pathogenic variants in individuals with some features of Beta Thalassemia as well as in clinically normal indivduals (e.g. Honig_1982, Chang_2002, Fucharoen_2001, 2005, Zhang_2017). These reports do not provide unequivocal conclusions about association of the variant with Beta Thalassemia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 12403500, 6252122, 6025242, 5967288, 19631632, 19460936, 20838957, 6859036, 5970505, 5415584, 21599435, 7216820, 15938724, 11422410, 4421749, 7161111, 28407371). ClinVar contains an entry for this variant (Variation ID: 15214). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | May 22, 2023 | The HBB c.170G>A (p.Gly57Asp) variant (also known as Hb J-Bangkok, Hb J-Meinung) has been reported in the published literature to have normal stability and oxygen affinity (PMID: 7216820 (1981)), with normal clinical presentation in heterozygotes (PMIDs: 7216820 (1981), 6025242 (1967)). Compound heterozygous individuals carrying this variant and a beta+ thalassemia variant on the other allele presented as beta-thalassemia trait, suggesting this variant did not aggravate the phenotype (PMIDs: 23568723 (2013), 12403500 (2002), 1428942 (1992)). The frequency of this variant in the general population, 0.00025 (5/19946 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, we are unable to determine the clinical significance of this variant. - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 19, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at